Prepaire Labs Launches SHIELD, AI Platform Targeting Real-Time Outbreak Management

4 min
Prepaire Labs unveiled SHIELD™, a real-time biological intelligence and response platform.
It aims to shift from ‘after the fact’ reporting to rapid action.
The system blends surveillance, AI risk analysis and Digital Twin modelling.
Deployable in sovereign environments, it keeps sensitive health data within borders.
The challenge now is embedding it into national workflows without ‘a faff’.
Prepaire Labs, a UAE-based BioAI company operating out of Masdar City in Abu Dhabi, has officially introduced SHIELD™, a real-time biological intelligence and response platform aimed at transforming how outbreaks are detected and managed. The launch took place during ISNR Abu Dhabi 2026 and marks the company’s first commercial product release.
The timing feels anything but random. With renewed global concern following the latest Ebola outbreak in the Democratic Republic of Congo, conversations around preparedness are back at the top of policy agendas. For many governments, the uncomfortable truth is that outbreak reporting still often comes after the damage has begun. SHIELD is designed to narrow that gap, to move from detection to operational response in real time.
At its core, the platform blends several complex capabilities into one operational system: outbreak surveillance, environmental risk modelling, pathogen intelligence, Digital Twin modelling, pharmacogenomics, AI-driven risk analysis, and automated response workflows. That’s a mouthful, I know. But in simple terms, it’s about connecting data, simulating scenarios, and coordinating action quickly, without the usual silos slowing things down.
What stands out is how SHIELD can be deployed. It operates via cloud, hybrid, or fully sovereign on-premise environments using what the company calls Shield Spark edge nodes. This means sensitive health data can remain within national borders while still contributing to a federated intelligence network. In a region where data sovereignty is increasingly non-negotiable, that detail is spot on.
The system is built to serve a wide mix of users, from national public health systems and hospital networks to military and civil defence units, as well as NGOs and humanitarian teams working in resource-limited settings. It also supports operations in high-containment laboratories, including BSL‑3 and BSL‑4 facilities, where speed and airtight coordination can make all the differense.
Professor Min Park, Co-Founder of Prepaire Labs, said: “The world has spent decades building systems that report outbreaks after the fact. SHIELD was built to reduce the time between signal detection and operational response. We believe biological preparedness will become one of the defining infrastructure challenges of the next decade. Faster intelligence, faster sequencing, and faster coordination are now essential capabilities. Platforms like SHIELD represent a major step toward integrated preparedness infrastructure.”
The architecture allows hospitals and frontline facilities to plug into the SHIELD network without exporting sensitive patient data. Institutions can deploy a core preparedness layer and then selectively activate more advanced tools such as Digital Twins, pathogen sequencing, pharmacogenomic analysis, and AI-driven therapeutic workflows through HAiLO™ systems.
SHIELD also connects with Prepaire Labs’ broader ecosystem: GenetiQ™ Digital Twin systems, Shield Sentinel™ pathogen sequencing kits, autonomous field laboratories, UAV logistics, and SPARK™ sovereign intelligence nodes. The long-term ambition, according to the company, is to create a globally distributed biological intelligence infrastructure that reduces response latency and accelerates therapeutic development during health emergencies.
Importantly, a humanitarian access framework has been announced for qualified NGOs and outbreak response organisations. Approved operators in resource-constrained environments will be able to deploy SHIELD while contributing governed epidemiological intelligence back into the wider network. On the flip side, ensuring equitable access without creating dependency will be a balancing act — and I reckon that’s where execution will matter more than ambition.
From where we sit at Arageek, covering startups that aim to energise and empower the region, it’s interesting to see biological preparedness increasingly framed as infrastructure, not just healthcare. A few years ago, many founders in MENA were pitching fintech or e-commerce solutions. Now, we’re seeing deeper tech aimed at sovereign resilience. It’s a different ball game altogether.
Prepaire Labs describes itself as a biological AI infrastructure company focused on disease modelling, sovereign biological intelligence, precision diagnostics, and AI-driven countermeasure development. With SHIELD now commercially available for deployment across sovereign, enterprise, hospital, and humanitarian settings, the real test begins. Building the system is one thing. Embedding it into national workflows without making it a bit of a faff? That’s the next challenge.
Still, in a world where biological risks are becoming more complex and interconnected, platforms promising faster intelligence and coordinated response are likely to draw serious attention, especially across regions thinking carefully about health security beyond headlines and crisis cycles.
🚀 Got exciting news to share?
If you're a startup founder, VC, or PR agency with big updates—funding rounds, product launches 📢, or company milestones 🎉 — AraGeek English wants to hear from you!
✉️ Send Us Your Story 👇









